PITX2

Prediction efficiency of PITX2 DNA methylation for prostate cancer survival

Z. M. Luan, Zhang, H., Qu, X. L., Luan, Z. M., Zhang, H., Qu, X. L., Luan, Z. M., Zhang, H., and Qu, X. L., Prediction efficiency of PITX2 DNA methylation for prostate cancer survival, vol. 15, p. -, 2016.

This study determined the level of PITX2 methylation in prostate cancer and benign tissues and its relationship with the postoperative survival rate. Forty-four patients with prostate cancer who underwent radical prostatectomy and 43 patients with benign prostatic hyperplasia were selected. DNA was extracted from the tissues and PITX2 methylation status was quantitatively analyzed by using the EpiTect MethyLight method.

Subscribe to PITX2